id	metarevistapublica_asoneumocito_revistacolombianadeneumologia_28_article_882
record_format	ojs
spelling	Objective: The aim of this observational study was to collect information about the effectiveness and safety of Ciclesonide on treatment of mildpersistent asthma in a cohort population in Colombia.Material and methods: Longitudinal and descriptive study of a cohort without group control. Inclusion data from 2005 to 2006. We showed data of 264 clinical records of patients with persistent asthma diagnosis.Results: A homogenous distribution by sort is observed (52% of men and 48% women). The average age was 31.7 years (standard deviation of 19.5 years). Before the beginning of ciclesonide, 5.7% of patients had not used medicines to treat the asthma, only 2.6% had used inhaled or oral corticosteroids, 23.5% had used one drug and 42.4% used 3 or more drugs. The lack of effectiveness of previous treatment was the main reason to initiate ciclesonide. At the last evaluation 93% of the patients described as “good to excellent” the performance of ciclesonide.Conclusions: Ciclesonide is an effective and safe corticosteroid, useful for the treatment of patients greater to 6 years of age with mild persistent asthma. There are necessary programs of medical education that help to improve the level of knowledge on the treatment of asthma, because is observed lack of knowledge on therapeutic resources as it is the case of the inhaled corticotherapy Cifuentes , Luis Fernando Lopez , José Julián Colombia Ciclesonide Asthma Corticosteroids Colombia Ciclesonida Asma Corticoesteroides 19 4 Artículo de revista Journal article 2007-12-03T00:00:00Z 2007-12-03T00:00:00Z 2007-12-03 application/pdf Asociación Colombiana de Neumología y Cirugía de Tórax Revista Colombiana de Neumología 0121-5426 2538-9513 https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/882 https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/882 spa https://creativecommons.org/licenses/by-nc-nd/4.0 Revista Colombiana de Neumología - 2023 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. 210 216 https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/882/715 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_2df8fbb1 http://purl.org/redcol/resource_type/ART info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication
institution	ASOCIACION COLOMBIANA DE NEUMOLOGIA Y CIRUGIA DE TORAX
thumbnail	https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADENEUMOLOGIAYCIRUGIADETORAX/logo.png
country_str	Colombia
collection	Revista Colombiana de Neumología
description_eng	Objective: The aim of this observational study was to collect information about the effectiveness and safety of Ciclesonide on treatment of mildpersistent asthma in a cohort population in Colombia.Material and methods: Longitudinal and descriptive study of a cohort without group control. Inclusion data from 2005 to 2006. We showed data of 264 clinical records of patients with persistent asthma diagnosis.Results: A homogenous distribution by sort is observed (52% of men and 48% women). The average age was 31.7 years (standard deviation of 19.5 years). Before the beginning of ciclesonide, 5.7% of patients had not used medicines to treat the asthma, only 2.6% had used inhaled or oral corticosteroids, 23.5% had used one drug and 42.4% used 3 or more drugs. The lack of effectiveness of previous treatment was the main reason to initiate ciclesonide. At the last evaluation 93% of the patients described as “good to excellent” the performance of ciclesonide.Conclusions: Ciclesonide is an effective and safe corticosteroid, useful for the treatment of patients greater to 6 years of age with mild persistent asthma. There are necessary programs of medical education that help to improve the level of knowledge on the treatment of asthma, because is observed lack of knowledge on therapeutic resources as it is the case of the inhaled corticotherapy
author	Cifuentes , Luis Fernando Lopez , José Julián
spellingShingle	Cifuentes , Luis Fernando Lopez , José Julián Colombia Ciclesonide Asthma Corticosteroids Colombia Ciclesonida Asma Corticoesteroides
author_facet	Cifuentes , Luis Fernando Lopez , José Julián
topic	Colombia Ciclesonide Asthma Corticosteroids Colombia Ciclesonida Asma Corticoesteroides
topic_facet	Colombia Ciclesonide Asthma Corticosteroids Colombia Ciclesonida Asma Corticoesteroides
topicspa_str_mv	Colombia Ciclesonida Asma Corticoesteroides
citationvolume	19
citationissue	4
publisher	Asociación Colombiana de Neumología y Cirugía de Tórax
ispartofjournal	Revista Colombiana de Neumología
source	https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/882
language	spa
format	Article
rights	https://creativecommons.org/licenses/by-nc-nd/4.0 Revista Colombiana de Neumología - 2023 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_6501
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2007-12-03
date_accessioned	2007-12-03T00:00:00Z
date_available	2007-12-03T00:00:00Z
url	https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/882
url_doi	https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/882
issn	0121-5426
eissn	2538-9513
citationstartpage	210
citationendpage	216
url2_str_mv	https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/882/715
_version_	1811200747417632768

.

Código QR

Estadísticas y Métricas Alternativas

Títulos similares